1. Home
  2. ALBT vs PTHL Comparison

ALBT vs PTHL Comparison

Compare ALBT & PTHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALBT
  • PTHL
  • Stock Information
  • Founded
  • ALBT 2014
  • PTHL 1998
  • Country
  • ALBT United States
  • PTHL China
  • Employees
  • ALBT N/A
  • PTHL N/A
  • Industry
  • ALBT Biotechnology: Biological Products (No Diagnostic Substances)
  • PTHL
  • Sector
  • ALBT Health Care
  • PTHL
  • Exchange
  • ALBT Nasdaq
  • PTHL Nasdaq
  • Market Cap
  • ALBT 8.8M
  • PTHL 10.0M
  • IPO Year
  • ALBT N/A
  • PTHL 2024
  • Fundamental
  • Price
  • ALBT $2.21
  • PTHL $0.62
  • Analyst Decision
  • ALBT
  • PTHL
  • Analyst Count
  • ALBT 0
  • PTHL 0
  • Target Price
  • ALBT N/A
  • PTHL N/A
  • AVG Volume (30 Days)
  • ALBT 44.3K
  • PTHL 104.8K
  • Earning Date
  • ALBT 11-11-2025
  • PTHL 01-01-0001
  • Dividend Yield
  • ALBT N/A
  • PTHL N/A
  • EPS Growth
  • ALBT N/A
  • PTHL N/A
  • EPS
  • ALBT N/A
  • PTHL N/A
  • Revenue
  • ALBT $1,159,091.00
  • PTHL $448,196.00
  • Revenue This Year
  • ALBT N/A
  • PTHL N/A
  • Revenue Next Year
  • ALBT N/A
  • PTHL N/A
  • P/E Ratio
  • ALBT N/A
  • PTHL N/A
  • Revenue Growth
  • ALBT N/A
  • PTHL N/A
  • 52 Week Low
  • ALBT $1.87
  • PTHL $0.51
  • 52 Week High
  • ALBT $11.66
  • PTHL $32.00
  • Technical
  • Relative Strength Index (RSI)
  • ALBT 40.69
  • PTHL 31.93
  • Support Level
  • ALBT $2.13
  • PTHL $0.58
  • Resistance Level
  • ALBT $2.28
  • PTHL $0.67
  • Average True Range (ATR)
  • ALBT 0.11
  • PTHL 0.06
  • MACD
  • ALBT -0.01
  • PTHL 0.07
  • Stochastic Oscillator
  • ALBT 25.37
  • PTHL 28.16

About ALBT Avalon GloboCare Corp.

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

About PTHL Pheton Holdings Ltd Class A Ordinary Shares

Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.

Share on Social Networks: